Skip to main content
Journal ArticleOPEN ACCESS

Author Correction: RAS-targeted therapies: is the undruggable drugged?

  • Moore A
  • Rosenberg S
  • McCormick F
  • et al.
Nature Reviews Drug Discovery (2020) 19(12) 902-902
DOI: 10.1038/s41573-020-0089-1
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In Figure 1, gefitinib was misspelled and gefitinib and erlotinib were mislabelled as mAbs. In the main text, GDC-0994 was incorrectly called GDC-0944 in one instance and GDC-0094 in one instance. These corrections have been made to the online version of the article.

Cite

CITATION STYLE

APA

Moore, A. R., Rosenberg, S. C., McCormick, F., & Malek, S. (2020). Author Correction: RAS-targeted therapies: is the undruggable drugged? Nature Reviews Drug Discovery, 19(12), 902–902. https://doi.org/10.1038/s41573-020-0089-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free